Journal info
|
||||
Select Journal
Journals
Bratislava Medical Journal 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Ekologia - Ecology Endocrine Regulations General Physiology and Biophysics Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudba 2025Webshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Bratislava Medical Journal Vol.116, No.12, p.746-750, 2015 |
||
Title: The effects of low and high doses of sugammadex on kidney tissue in streptozotocin-induced diabetic rats | ||
Author: G. Kip, H. C. Turgut, M. Alkan, M. E. Aydin, M. E. Erbatur, H. A. Kiraz, S. Kartal, H. Boyunaga, F. M. Comu, O. Erdem, M. Arslan, Y. Unal | ||
Abstract: BACKGROUND: Sugammadex is primarily excreted via renal route. We investigated effects of low and high doses of sugammadex (16 mg/kg versus 96 mg/kg) on renal tissue samples of streptozotocin-induced diabetic rats. MATERIAL AND METHODS: Twenty-four Wistar albino rats were divided into 4 groups. Group C (control – 0.9 % NaCl), Group DC (diabetes control; 55 mg/kg streptozotocin, IP, only), Group DR-16S (diabetes-rocuronium – 16 mg sugammadex, IV.) and Group DR-96S (diabetes- rocuronium – 96 mg sugammadex, IV). Renal tissue histopathological evaluation and antioxidant status (measurements of MDA levels and NO activities) were studied. RESULTS: Significantly higher levels of all inflammation parameters (inflammation, degeneration/necrosis, tubular dilatation, tubular cell degeneration, dilatation in Bowman’s space, tubular hyaline casts, and lymphocyte infiltration) were found in the 96 mg/kg sugammadex group. Higher MDA tissue levels and lower NO activity were found in the 96 mg/kg sugammadex group. DISCUSSION: We can conclude that high-dose (96 mg/kg) sugammadex administration resulted in significant renal tissue damage in diabetic rats. As a consequence, low doses of sugammadex have to be preferred in diabetic patients (Tab. 2, Fig. 4, Ref. 26). |
||
Keywords: sugammadex, streptozotocin, diabetes, renal damage. | ||
Published online: 15-Dec-2015 | ||
Year: 2015, Volume: 116, Issue: 12 | Page From: 746, Page To: 750 | |
doi:10.4149/BLL_2015_146 |
||
|
![]() |
|